Ocrelizumab for Psychosis by Autoimmunity
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT03971487
- Locations
- 🇺🇸
Houston Methodist Research Institute, Houston, Texas, United States
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 39
- Registration Number
- NCT03820141
- Locations
- 🇺🇸
Houston Methodist Cancer Center, Houston, Texas, United States
Olaparib in Combination with Vorinostat in Patients with Relapsed/Refractory And/or Metastatic Breast Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-11-15
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 28
- Registration Number
- NCT03742245
- Locations
- 🇺🇸
Houston Methodist Cancer Center, Houston, Texas, United States
Stroke Recovery and Music or No Music
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT03608904
- Locations
- 🇺🇸
Houston Methodist, Houston, Texas, United States
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 62
- Registration Number
- NCT03603405
- Locations
- 🇺🇸
Houston Methodist Neurological Institute, Houston, Texas, United States
Brain Targets in Patients With Bladder Emptying Difficulties
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-07-02
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 11
- Registration Number
- NCT03574610
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
- First Posted Date
- 2018-05-31
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 60
- Registration Number
- NCT03541928
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Heart Failure Hospital Readmissions and Physical Therapy
Completed
- Conditions
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 102
- Registration Number
- NCT03517514
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Clinical Trial Readiness for SCA1 and SCA3
- First Posted Date
- 2018-04-04
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 200
- Registration Number
- NCT03487367
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Mesenchymal Stromal Cells in Living Donor Kidney Transplantation
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 24
- Registration Number
- NCT03478215
- Locations
- 🇺🇸
Houston Methodist Hospital System, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath